APA (7th ed.) Citation

GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C., & MATUCHANSKY, C. (2007). Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double‐blind, controlled trial. Alimentary Pharmacology and Therapeutics, 26(3), 475-486. https://doi.org/10.1111/j.1365-2036.2007.03362.x

Chicago Style (17th ed.) Citation

GUYONNET, D., O. CHASSANY, P. DUCROTTE, C. PICARD, M. MOURET, C.‐H MERCIER, and C. MATUCHANSKY. "Effect of a Fermented Milk Containing Bifidobacterium Animalis DN‐173 010 on the Health‐related Quality of Life and Symptoms in Irritable Bowel Syndrome in Adults in Primary Care: A Multicentre, Randomized, Double‐blind, Controlled Trial." Alimentary Pharmacology and Therapeutics 26, no. 3 (2007): 475-486. https://doi.org/10.1111/j.1365-2036.2007.03362.x.

MLA (9th ed.) Citation

GUYONNET, D., et al. "Effect of a Fermented Milk Containing Bifidobacterium Animalis DN‐173 010 on the Health‐related Quality of Life and Symptoms in Irritable Bowel Syndrome in Adults in Primary Care: A Multicentre, Randomized, Double‐blind, Controlled Trial." Alimentary Pharmacology and Therapeutics, vol. 26, no. 3, 2007, pp. 475-486, https://doi.org/10.1111/j.1365-2036.2007.03362.x.